Figure 3.
Correlation of CEBPA mutational status with clinical outcome. (A) EFS among the cohort according to CEBPA-WT vs CEBPA-dm vs CEBPA-bZip status; (B) RR according to CEBPA-WT vs CEBPA-dm vs CEBPA-bZip status; (C) OS for the cohort according CEBPA-WT vs CEBPA-dm vs CEBPA-bZip status.